Infinity Pharmaceuticals, Inc. (INFIQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
+0.0002 (1,900.00%)
Jan 23, 2025, 8:00 PM EDT
Infinity Pharmaceuticals Revenue
Infinity Pharmaceuticals had revenue of $583.00K in the quarter ending June 30, 2023, a decrease of -15.01%. This brings the company's revenue in the last twelve months to $2.57M, up 15.88% year-over-year. In the year 2022, Infinity Pharmaceuticals had annual revenue of $2.59M with 39.56% growth.
Revenue (ttm)
2.57M
Revenue Growth
+15.88%
P/S Ratio
0.00
Revenue / Employee
85.63K
Employees
30
Market Cap
91.00
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 2.59M | 735.00K | 39.56% |
Dec 31, 2021 | 1.86M | 139.00K | 8.09% |
Dec 31, 2020 | 1.72M | -1.33M | -43.62% |
Dec 31, 2019 | 3.05M | -19.10M | -86.23% |
Dec 31, 2018 | 22.15M | 16.15M | 269.10% |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Dec 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SS Innovations International | 20.65M |
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 200.90M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 210.49M |
American Oncology Network | 1.76B |